A descriptive qualitative study.
To explore why individuals with spinal cord injury (SCI) choose to use cannabis to manage their pain and their experiences in doing so.
Community-dwelling adults with SCI in New Zealand.
Semi-structured interviews were conducted with individuals who had a SCI, experienced pain, and self-reported use of cannabis to manage their pain. Interviews were recorded, transcribed, and subject to thematic analysis.
Eight individuals participated in this study. We interpreted six themes that captured the participants’ perspectives regarding their choice to, and perceptions of, using cannabis to manage SCI pain. Participants were motivated to use cannabis when other pain management strategies had been ineffective and were well-informed, knowledgeable cannabis consumers. Participants reported cannabis reduced their pain quickly and enabled them to engage in activities of daily living and participate in life roles without the drowsiness of traditional prescribed pain medication. Despite the positive aspects, participants were concerned about the irregularity of supply and inconsistent dosage.
Findings show that cannabis is used to reduce pain after SCI and enable increased community participation. Findings suggest that future studies examining the efficacy of cannabinoids in managing pain include function and participation outcome measures rather than solely focusing on measuring pain intensity. Focusing on meaningful outcomes may contribute to a greater understanding of the experiences of people with SCI.
Subscribe to Journal
Get full journal access for 1 year
We are sorry, but there is no personal subscription option available for your country.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Adriaansen JJ, Ruijs LE, van Koppenhagen CF, van Asbeck FW, Snoek GJ, van Kuppevelt D. et al. Secondary health conditions and quality of life in persons living with spinal cord injury for at least ten years. J Rehab Med. 2016;48:853–60.
Hadjipavlou G, Cortese AM, Ramaswamy B. Spinal cord injury and chronic pain. BJA Educ. 2016;16:264–8.
Kirshblum S, Campagnolo DI, DeLisa JA. Spinal cord medicine. Philadelphia: Lippincott Williams and Wilkins; 2002.
Finnerup NB. Pain in patients with spinal cord injury. Pain. 2013;154 Suppl 1:S71–6.
Piatt JA, Nagata S, Zahl M, Li J, Rosenbluth JP. Problematic secondary health conditions among adults with spinal cord injury and its impact on social participation and daily life. J Spinal Cord Med. 2016;39:693–8.
Hill K. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems. JAMA. 2015;313:2474–83.
The National Academies Press. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington: The National Academy of Sciences; 2017.
Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B. et al. A randomised, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain. 2008;9:506–21.
Hauser W, Finn DP, Kalso E, Krcevski-Skvarc N, Kress HG, Morlion B. et al. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain. 2018;22:1547–64.
Campbell G, Stockings E, Neielsen S. Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. Eur Arch Psychiatry Clin Neurosci. 2019;269:135–44.
Ware MA, Wang T, Shapiro S, Collet J. Cannabis for the management of pain. Assessment of safety study. J Pain. 2015;16:1233–42.
Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta-9-tetrahydrocannabinol, cannabidiol and delta-9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153:199–215.
Hawley LA, Ketchum JM, Morey C, Collins K, Charlifue S. Cannabis use in individuals with spinal cord injury or moderate to severe traumatic brain injury in Colorado. Arch Phys Med Rehabilitation. 2018;99:1584–90.
Stillman M, Mallow M, Ransom T, Gustafson K, Bell A, Graves D. Attitudes toward and knowledge of medical cannabis among individuals with spinal cord injury. Spinal Cord Ser Cases. 2019;5:1–6.
Stillman M, Capron M, Mallow M, Ransom T, Gustafson K, Bell A. et al. Utilization of medicinal cannabis for pain by individuals with spinal cord injury. Spinal Cord Ser Cases. 2019;5:1–6.
Ministry of Health. Misuse of Drugs (Medicinal Cannabis) Amendment Act. 2019; https://http://www.health.govt.nz/our-work/regulation-health-and-disability-system/medicines-control/medicinal-cannabis/misuse-drugs-medicinal-cannabis-amendment-act. Accessed 16 July 2019.
Ministry of Health. Cannabis use 2012/13: New Zealand Health Survey. Wellington: Ministry of Health; 2015.
Mucke M, Phillips T, Radbruch L, Petzke F, Haeuser W. Cannabis‐based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;7:1–92.
Casey S, Vaughan C. Plant-based cannabinoids for the treatment of chronic neuropathic pain. Medicines. 2018;5:67.
Yanes JA, McKinnell ZE, Reid MA, Busler JN, Michel JS, Pangelinan MM. et al. Effects of cannabinoid administration for pain: a meta-analysis and meta-regression. Exp Clin Psychopharmacol. 2019;27:370–82.
Berliner J, Collins K, Coker J. Cannabis conundrum. Spinal Cord Ser Cases. 2018;4:1–3.
Graves D. Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury. Spinal Cord Ser Cases. 2018;4:1–3.
Drossel C, Forcheimer M, Meade MA. Characteristics of individuals with spinal cord injury who use cannabis for therapeutic purposes. topics in spinal cord injury. Rehabilitation. 2016;22:3–12.
Andresen SR, Biering-Sørensen F, Hagen EM, Nielsen JF, Bach FW, Finnerup NB. Cannabis use in persons with traumatic spinal cord injury in Denmark. J Rehabil Med. 2017;49:152–60.
Sadler GR, Lee HC, Lim RSH JF. Recruitment of hard‐to‐reach population subgroups via adaptations of the snowball sampling strategy. Nurse Health Sci. 2010;12:369–64.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
Braun V, Clarke V. Successful qualitative research: a practical guide for beginners. London: Sage; 2013.
Piper BJ, Beals ML, Abess AT, Nichols SD, Martin MW, Cobb CM. et al. Chronic pain patients’ perspectives of medical cannabis. Pain. 2017;158:1373–9.
Ballantyne JC, Sullivan MD. Intensity of chronic pain—the wrong metric? New Engl J Med. 2015;373:2098–9.
Stillman M, Graves DM, New PW, Bryce T, Alexander M. Survey on current treatments for pain after spinal cord damage. Spinal Cord Ser Cases. 2019;5:1–5.
Polit DF, Beck CT. Generalisation in quantitative and qualitative research: myths and strategies. Int J Nurs Stud. 2010;47:1451–8.
Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Educ Inf. 2004;22:63–75.
The research team would like to thank the person with SCI who advised on aspects of this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bourke, J.A., Catherwood, V.J., Nunnerley, J.L. et al. Using cannabis for pain management after spinal cord injury: a qualitative study. Spinal Cord Ser Cases 5, 82 (2019) doi:10.1038/s41394-019-0227-3